Reuters Award Runner Up
This press release is suitable for all audiences.
Proveca is a runner up of the Reuters award – Valuable Medical Education/Awareness Initiative Award
Proveca is delighted to be one of the runners up for a Reuters award in the Valuable Medical Education/Awareness Initiative Award category at the Reuters Events Pharma Awards EU 2024. We are so pleased to have made it as one of the finalist runners up alongside some of the largest companies in the industry – an incredible achievement for Proveca.
The awards were announced on the keynote stage at the flagship event, Reuters Events: Pharma EU, Tuesday 16th April. The winner of this category was Boehringer Ingelheim, congratulations.
Helen Wilmshurst – Head of Marketing at Proveca
‘I was delighted to be at the awards and to find out that we were one of the runners up, to have achieved this recognition so far is amazing for Proveca and the team is delighted to have been considered. Congratulations to Boehringer Ingelheim very well deserved on your initiative.’
Dr Simon Bryson – CEO and co-founder of Proveca
‘I’m honoured and proud of this fantastic recognition for the Proveca team, who dedicate every day to improving children’s lives through innovation in healthcare. I’m delighted the team’s pioneering work in medical education has been recognised as a runner up in this prestigious award category. Congratulations to the whole Proveca team!’
About Proveca
Proveca is a global pharmaceutical company who specialise in the development and licensing of medicines to address the unmet medical needs for children. Working with clinicians, parents, carers and children, Proveca are leading the way to provide licenced medicines that are tailored to children’s specific requirements.
INT-NON-24-0017
Created April 2024